Gene Transfer into the CNS Using Recombinant Adeno-associated Virus: Analysis of Vector DNA Forms Resulting in Sustained Expression

References

• Afione S. A., Conrad C. K., Kearns W. G., Chunduru S., Adams R., Reynolds T. C., Guggino W. B., Cutting G. R., Carter B.J., Flotte T. R. In vivo model ofadeno-associated virus vector persistence and rescue. J. Virol. 1996; 70: 3235–3241
   PubMed Web of Science ®Google Scholar
• Alexander I. E., Russell D. W., Spence A. M., Miller A. D. Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 1996; 7: 841–850
   PubMed Web of Science ®Google Scholar
• Baskar J. F., Smith P. P., Nilaver G., Jupp R. A., Hoffmann S., Peffer N. J., Tenney D. J., Colberg-Poley A. M., Ghazal P., Nelson J. A. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J. Virol. 1996; 70: 3207–3214
   PubMed Web of Science ®Google Scholar
• Berns K. I., Rose J. A. Evidence for a single-stranded adenovirus-associated virus genome: isolation and separation of complementary single strands. J. Virol. 1970; 5: 693–699
   PubMed Web of Science ®Google Scholar
• Blomer U., Naldini L., Verma I. M., Trono D., Gage F. H. Applications of gene therapy to the CNS. Hum. Mol. Genet. 1996; 5: 1397–1404
   PubMed Web of Science ®Google Scholar
• Clark K. R., Sferra T. J., Johnson P. R. Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 1997; 8: 659–669
   PubMed Web of Science ®Google Scholar
• Clark K. R., Voulgaropoulou F., Johnson P. R. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Therapy 1996; 3: 1124–1132
   PubMed Web of Science ®Google Scholar
• Clark K. R., Voulgaropoulou F., Fraley D. M., Johnson P. R. Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 1995; 6: 1329–1341
   PubMed Web of Science ®Google Scholar
• Clark K. R., Liu X., McGrath J., Johnson P. R. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 1999; 10: 1031–1039
   PubMed Web of Science ®Google Scholar
• Doll R. F., Crandall J. E., Dyer C. A., Aucoin J. M., Smith F. I. Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors. Gene Therapy 1996; 3: 437–447
   PubMed Web of Science ®Google Scholar
• Du B., Wu P., Boldt-Houle D. M., Terwilliger E. F. Efficient transduction of human neurons with an adeno-associated virus vector. Gene Therapy 1996; 3: 254–261
   PubMed Web of Science ®Google Scholar
• Duan D., Sharma P., Yang J., Yue Y., Dudus L., Zhang Y., Fisher K. J., Engelhardt J. F. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 1998; 72: 8568–8577
   PubMed Web of Science ®Google Scholar
• During M. J., Samulski R. J., Elsworth J. D., Kaplitt M. G., Leone P., Xiao X., Li J., Freese A., Taylor J. R., Roth R. H., Sladek J.R., Jr., O'Maliey K. L., Redmond D.E., Jr. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Therapy 1998; 5: 820–827
   PubMed Web of Science ®Google Scholar
• Fan D. S., Ogawa M., Fujimoto K. I., Ikeguchi K., Ogasawara Y., Urabe M., Nishizawa M., Nakano I., Yoshida M., Nagatsu I., Ichinose H., Nagatsu T., Kurtzman G. J., Ozawa K. Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors. Hum. Gene Ther. 1998; 9: 2527–2535
   PubMed Web of Science ®Google Scholar
• Fisher K. J., Jooss K., Alston J., Yang Y., Haecker S. E., High K., Pathak R., Raper S. E., Wilson J. M. Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med. 1997; 3: 306–312
   PubMed Web of Science ®Google Scholar
• Flannery J. G., Zolorukhin S., Vaquero M. I., LaVail M. M., Muzyczka N., Hauswirth W. W. Efficient photo-receptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 1997; 94: 6916–6921
   PubMed Web of Science ®Google Scholar
• Giraud C., Winocour E., Berns K. I. Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J. Virol. 1995; 69: 6917–6924
   PubMed Web of Science ®Google Scholar
• Glorioso J. C., DeLuca N. A., Fink D. J. Development and application of herpes simplex virus vectors for human gene therapy. Aimu. Rev. Microbiol. 1995; 49: 675–710
   PubMed Web of Science ®Google Scholar
• Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mot. Biol. 1967; 26: 365–369
   PubMed Web of Science ®Google Scholar
• Kaplitt M. G., Leone P., Samulski R. J., Xiao X., Pfaff D. W., O'Malley K. L., During M. J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 1994; 8: 148–154
   PubMed Web of Science ®Google Scholar
• Karpati G., Lochmulier H. J.N., Durham H. The principles of gene therapy for the nervous system. TINS 1996; 19: 49–54
   PubMed Web of Science ®Google Scholar
• Kessler P. D., Podsakoff G. M., Chen X., McQuiston S. A., Colosi P. C., Matelis LA., Kurtzman G. J., Byrne B. J. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 1996; 93: 14082–14087
   PubMed Web of Science ®Google Scholar
• Klein R. L., McNamara R. K., King M. A., Lenox R. H., Muzyczka N., Meyer E. M. Generation of aberrant sprouting in the adult rat brain by GAP-43 somatic gene transfer. Bain Res. 1999; 832: 136–144
   PubMed Web of Science ®Google Scholar
• Kotin R. M., Siniscalco M., Samulski R. J., Zhu X. D., Hunter L., Laughlin C. A., Linden R. M., Ward P., Giraud C., Winocour E., Berns K.L. Site-specific integration by adeno-associatcd virus. Proc. Natl. Acad. Sci. USA 1990; 93(11)288, 11, 294
   Google Scholar
• Linden R. M., Ward P., Giraud C., Winocour E., Berns K. I. Site-specific integration by adeno-associatcd virus. Proc. Natl. Acad. Sci. USA 1996; 93(11)288–11; 294
   Google Scholar
• Lo W. D., Qu G., Sferra T. J., Clark R., Chen R., Johnson P. R. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum. Gene Ther. 1999; 10: 201–213
   PubMed Web of Science ®Google Scholar
• Mandel R. J., Spratt S. K., Snyder R. O., Leff S. E. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc. Natl. Acad. Sci. USA 1997; 94: 14083–14088
   PubMed Web of Science ®Google Scholar
• McCown T. J., Xiao X., Li J., Breese G. R., Samulski R. J. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 1996; 713: 99–107
   PubMed Web of Science ®Google Scholar
• McLaughlin S. K., Collis P., Hermonat P. L., Muzyczka N. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 1988; 62: 1963–1973
   PubMed Web of Science ®Google Scholar
• Miao C. H., Snyder R. O., Schowalter D. B., Patijn G. A., Donahue B., Winther B., Kay M. A. The kinetics of rAAV integration in the liver. Nat. Genet. 1998; 19: 13–15
   PubMed Web of Science ®Google Scholar
• Nakai H., Iwaki Y., Kay M. A., Couto L. B. Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J. Virol. 1999; 73: 5438–5447
   PubMed Web of Science ®Google Scholar
• Peel A. L., Zolotukhin S., Schrimsher G. W., Muzyczka N., Reier P. J. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Therapy 1997; 4: 16–24
   PubMed Web of Science ®Google Scholar
• Rolling F., Shen W. Y., Tabarias H., Constable I., Kanagasingam Y., Barry C. J., Rakoczy P. E. Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography. Hum. Gene Ther. 1999; 10: 641–648
   PubMed Web of Science ®Google Scholar
• Russell D. W., Miller A. D., Alexander LA. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 1994; 91: 8915–8919
   PubMed Web of Science ®Google Scholar
• Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 1989
   Google Scholar
• Samulski R. J., Chang L. S., Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 1989; 63: 3822–3828
   PubMed Web of Science ®Google Scholar
• Samulski R. J., Long-Sheng C., Shenk T. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 1987; 61: 3096–3101
   PubMed Web of Science ®Google Scholar
• Samulski R. J., Zhu X., Xiao X., Brook J. D., Housman D. E., Epstein N., Hunter L. A. Targeted integration of adeno-associatcd virus (AAV) into human chromosome 19. EMBO J. 1991; 10: 3941–3950
   PubMed Web of Science ®Google Scholar
• Snyder R. O., Miao C. H., Patijn C. H., Spratt C. H., Danos O., Nagy D., Gown A. M., Winther B., Meuse B., Cohen B., Thompson A. R., Kay M. A. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet. 1997; 16: 270–276
   PubMed Web of Science ®Google Scholar
• Suhr S. T., Gage F. H. Gene therapy in the central nervous system: the use of recombinant retroviruses. Arch. Neurol. 1999; 56: 287–292
   PubMed Web of Science ®Google Scholar
• Wallace R. B., Miyada C. G. Oligonucleotide probes for the screening of recombinant DNA libraries. Guide to Molecular Cloning Techniques, S. L. Berger, A. R. Kimmel. Harcourt Brace Jovanovich Publishers, San Diego, CA 1987; 432–442
   Google Scholar
• Weitzman M. D., Kyostio S. R., Kotin R. M., Owens R. A. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. USA 1994; 91: 5808–5812
   PubMed Web of Science ®Google Scholar
• Wu P., Phillips M. I., Bui J., Terwilliger E. F. Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets. J. Virol. 1998; 72: 5919–5926
   PubMed Web of Science ®Google Scholar
• Xiao X., Xiao W., Li J., Samulski R. J. A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J. Virol. 1997; 71: 941–948
   PubMed Web of Science ®Google Scholar
• Xiao X., Li J., Samulski R. J. Efficient long-term gene transfer into muscle tissue of-immunocompetent mice by adeno-associated virus vector. J. Virol. 1996; 70: 8098–8108
   PubMed Web of Science ®Google Scholar